KraneShares Hang Seng TECH Index ETF vs GeneDx Holdings Corp — how do they compare? KraneShares Hang Seng TECH Index ETF trades at $11.8 (market cap $45.04M), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: GeneDx Holdings Corp is far larger — about 44.8× KraneShares Hang Seng TECH Index ETF's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold KraneShares Hang Seng TECH Index ETF for 44 Days and GeneDx Holdings Corp for 19 Days on average.
| KTEC | WGS | |
|---|---|---|
Market Cap | $45.04M | $2.02B |
Volume | 29,043 | 734,640 |
Sector | Sector/Thematic | Health |
52-Week High | $18.73 | $167.51 |
52-Week Low | $11.41 | $34.51 |
Typical Hold Time | 44 Days | 19 Days |
Enterprise Value | — | $2.05B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →